Skip to main content

Table 1 Demographic and clinical characteristics of the study population according to FIGO Stage at diagnosis (n = 1575)

From: Cervical cancer in Ethiopia – predictors of advanced stage and prolonged time to diagnosis

Patient Characteristics

FIGO Stage

All Stages

I-IIa

IIb

III

IV

N

N (%)

N (%)

N (%)

N (%)

All Patients

1575

191 (12.1)

497 (31.6)

731 (46.4)

156 (9.9)

Age (years) (mean + SD) Range 21–93

48,9 ± 11,5

47.9 ± 11.4

49.6 ± 11.9

48.4 ± 11.3

50.9 ± 11.5

Menopausal status

 Premenopausal

344

41 (11.9)

102 (29.7)

175 (50.9)

26 (7.6)

 Postmenopausal

1212

148 (12.2)

386 (31.8)

548 (45.2)

130 (10.7)

 Unknown

19

2 (10.5)

9 (47.4)

8 (42.1)

0 (0)

Residence

 Rural

976

114 (11.7)

303 (31.0)

465 (47.6)

94 (9.6)

 Urban (Biggest 10 Cities)

599

77 (12.9)

194 (32.4)

266 (44.2)

62 (10.4)

HIV Status

 HIV-positive

135

11 (8.1)

37 (27.4)

74 (54.8)

13 (9.6)

 negative / unknown

1440

180 (12.5)

460 (31.9)

657 (45.6)

143 (9.9)

Parity (mean + SD) Range 0–17

6.1 ± 3.0

5.6 ± 2.9

6.6 ± 3.1

6.0 ± 3.0

6.5 ± 3.0

Marital Status

 Unmarried

12

2 (6.7)

4 (33.3)

5 (41.7)

1 (8.3)

 Early marriage (< 18 years)

1187

146 (12.3)

380 (32.0)

550 (46.3)

111 (9.4)

  > 18 years / unknown age

94

20 (21.3)

30 (31.9)

38 (40.4)

6 (6.4)

 Unknown Martial Status

282

23 (8.2)

83 (29.4)

138 (48.9)

38 (13.5)

Histology

 Squamous cell carcinoma

1488

170 (11.4)

462 (31.1)

711 (47.8)

145 (9.8)

 Adenocarcinoma

66

17 (25.8)

29 (43.9)

12 (18.2)

8 (12.1)

 Other

21

4 (19.0)

6 (28.6)

8 (38.1)

3 (14.3)

  1. FIGO International Federation of Gynecology and Obstetrics, SD Standard deviation, HIV Human immunodeficiency virus
  2. % as proportion among stages